Tumor immunology-mAb/bsAb/ADC efficacy
Our comprehensive platform evaluates antibody-related immunity efficacy through binding, apoptosis, cytotoxicity, and cell cycle assays.
Binding & apoptosis
Comprehensive binding assays and apoptosis evaluation for antibody candidates.
Cytotoxicity
ADCP, ADCC, CDC assays for antibody-mediated cell killing mechanisms.
ADC mechanisms
Internalization and bystander activity assays for Antibody Drug Conjugates.
Tumor immunology-PDO-immune cell co-culture
Immune checkpoint inhibitors
Testing platform for novel immune checkpoint inhibitors in patient-derived organoids.
Cytotoxicity
Evaluation of bispecific antibodies in co-culture systems with immune cells.
ADC mechanisms
Platform for testing cellular immunotherapy approaches using patient-derived models.